<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Rheumatoid arthritis is an autoimmune disease of unknown etiology that manifests as a persistent inflammatory synovitis and eventually destroys the joints. The immune system recognizes synovial cells as <italic>not self</italic> and consequently causes lymphocyte and antibody proliferation that is promoted by the pro-inflammatory cytokines, the most significant being tumor necrosis factor TNF-<italic>α</italic>. In the treatment of rheumatoid arthritis either monoclonal antibodies or soluble receptors are used to neutralize the TNF-<italic>α</italic> bioactivity, such as sTNFR2, Etanercept and Infliximab. In [M. Jit <italic>et al.</italic> Rheumatology 2005;44:323-331] a mathematical model that represents the TNF-<italic>α</italic> dynamics in the inflamed synovial joint within which locally produced TNF-<italic>α</italic> can bind to cell-surface receptors was proposed. It consists of four coupled ordinary differential equations, that were integrated numerically assuming a range of estimates of the key parameters. In this paper we complement the previous work by determining the general solution of those equations for specific conditions on the parameters. Then we characterize the behavior of TNF-<italic>α</italic> in the presence of different inhibitors and also evaluate the inhibitors effectiveness in the treatment of rheumatoid arthritis.</p></abstract>

Rheumatoid arthritis is an autoimmune disease of unknown etiology that manifests as a persistent inflammatory synovitis and eventually destroys the joints. The immune system recognizes synovial cells as not self and consequently causes lymphocyte and antibody proliferation that is promoted by the pro-inflammatory cytokines, the most significant being tumor necrosis factor TNF-α. In the treatment of rheumatoid arthritis either monoclonal antibodies or soluble receptors are used to neutralize the TNF-α bioactivity, such as sTNFR2, Etanercept and Infliximab. In [M. Jit et al. Rheumatology 2005;44:323-331] a mathematical model that represents the TNF-α dynamics in the inflamed synovial joint within which locally produced TNF-α can bind to cell-surface receptors was proposed. It consists of four coupled ordinary differential equations, that were integrated numerically assuming a range of estimates of the key parameters. In this paper we complement the previous work by determining the general solution of those equations for specific conditions on the parameters. Then we characterize the behavior of TNF-α in the presence of different inhibitors and also evaluate the inhibitors effectiveness in the treatment of rheumatoid arthritis.

Solution of a mathematical model for the treatment of rheumatoid arthritis

Communications in Applied and Industrial Mathematics

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

{"article-title":"Solution of a mathematical model for the treatment of rheumatoid arthritis"}

Rheumatoid arthritis is an autoimmune disease of unknown etiology that manifests as a persistent inflammatory synovitis and eventually destroys the joints. The...

Solution of a mathematical model for the treatment of rheumatoid arthritis

Pubblicato online: 11 mag 2019

Pagine: 12 - 24

Ricevuto: 02 apr 2017

Accettato: 19 feb 2018

DOI: https://doi.org/10.2478/caim-2019-0003

Parole chiave
Rheumatoid arthritis treatment model, ordinary differential equations, general solution

© 2019 L. Matteucci et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Solution of a mathematical model for the treatment of rheumatoid arthritis

Pubblicato online: 11 mag 2019

Pagine: 12 - 24

Ricevuto: 02 apr 2017

Accettato: 19 feb 2018

DOI: https://doi.org/10.2478/caim-2019-0003

Parole chiaveRheumatoid arthritis treatment model, ordinary differential equations, general solution

© 2019 L. Matteucci et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Parole chiave
Rheumatoid arthritis treatment model, ordinary differential equations, general solution